DUBLIN--(BUSINESS WIRE )--The "Contrast Media Injectors Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2022-2027" report has been added to ResearchAndMarkets.com's offering.
The global contrast media injectors market reached a value of US$ 1.46 Billion in 2021. Looking forward, the publisher expects the market to reach a value of US$ 2.16 Billion by 2027, exhibiting a CAGR of 6.75% during 2021-2027.
Keeping in mind the uncertainties of COVID-19, we are continuously tracking and evaluating the direct as well as the indirect influence of the pandemic on different end use sectors. These insights are included in the report as a major market contributor.
Contrast media (CM) injectors are medical devices utilized to inject CM into the body for enhancing the visibility of tissues for different medical imaging procedures. These procedures include computed tomography (CT), magnetic resonance imaging (MRI), positron emission tomography (PET) or magnetic resonance.
CM injectors find extensive applications in radiology, interventional cardiology, ambulatory surgical centers (ASCs), and diagnostic imaging centers across the globe. At present, they have evolved from simple, manual injectors to automated injectors that precisely control the amount of the CM agent used, facilitate automated data collection, and warn about potential hazards, such as air embolisms or extravasations.
Increasing preferences for minimally invasive (MI) medical procedures that offer numerous benefits, such as smaller incisions, less postoperative pain, faster recovery, and shorter hospital stay, represents one of the key factors bolstering the growth of the market.
Moreover, there is a rise in the use of automated CM injectors in cardiac imaging to help enhance patient safety and improve image quality. Besides this, leading players are focusing on offering personalized CM doses to patients using information from an electronic medical record (EMR) or picture archiving and communication system (PACS).
This, coupled with the emergence of syringeless power injectors, which aid in reducing CM waste, is facilitating the growth of the market. Apart from this, there is a widespread prevalence of cancers, including breast, lung, colon, rectum, and prostate cancers, around the world. This, along with the increasing number of regulatory approvals of contrast agents and the significant growth in the healthcare industry, is projected to create a positive outlook for the market in the upcoming years.
Key Questions Answered in This Report:
5 Global Contrast Media Injectors Market
6 Market Breakup by Product Type
7 Market Breakup by Injectors Type
9 Market Breakup by End User
For more information about this report visit https://www.researchandmarkets.com/r/gytj2q
ResearchAndMarkets.com Laura Wood, Senior Press Manager press@researchandmarkets.com For E.S.T Office Hours Call 1-917-300-0470 For U.S./CAN Toll Free Call 1-800-526-8630 For GMT Office Hours Call +353-1-416-8900
ResearchAndMarkets.com Laura Wood, Senior Press Manager press@researchandmarkets.com For E.S.T Office Hours Call 1-917-300-0470 For U.S./CAN Toll Free Call 1-800-526-8630 For GMT Office Hours Call +353-1-416-8900